# Medtronic and CathWorks enter co-promotion agreement with acquisition option

Medtronic has entered a strategic partnership with CathWorks, investing up to $75 million and co-promoting CathWorks' FFRangio System in the US, Europe, and Japan. Medtronic has an option to acquire CathWorks by July 2027 for up to $585 million.

- Type: Partnership
- Announced: 2022-07-12
- Value: $75.0M
- Status: announced
- Products: FFRangio System, coronary artery disease diagnostic technology
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Medtronic plc](https://endata.com/companies/19071.md) (partner)
- [CathWorks](https://endata.com/companies/64068.md) (partner)

## Sources

- [news.medtronic.com](https://news.medtronic.com/2022-07-12-Medtronic-announces-co-promotion-agreement-with-CathWorks,-with-path-toward-acquisition), 2022-07-12: "Medtronic will invest up to $75 million and immediately begin co-promotion of CathWorks' FFRangio® System in the U.S., Europe and Japan."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.